Wavemaker Three-Sixty Health

VC Pasadena, United States · Founded 2017

Wavemaker Three-Sixty Health is a specialized early-stage venture capital fund that invests in healthcare disruptors across digital health, health-tech, medical devices, and AI, explicitly excluding bio-pharma drug discovery. The fund leverages a unique network of over 300 healthcare-industry limited partners to provide commercial support and market entry assistance to its portfolio companies.

About Wavemaker Three-Sixty Health

Wavemaker Three-Sixty Health appears to be the same firm as Wavemaker 360 Health, with identical website (wavemaker360.com), LinkedIn handle, Twitter handle, and Crunchbase profile, suggesting this is a duplicate or alternate spelling of the same investor. Treating it as the same firm, the analysis is consistent: a US-based healthcare-focused early-stage venture firm explicitly oriented to digital health and healthcare technology investments. For healthcare AI founders, the same recommendation applies: Wavemaker Three-Sixty Health is a credible primary lead candidate for seed and Series A rounds in AI-driven clinical decision support, ambient documentation, payer automation, behavioral health technology, and care coordination platforms with early traction and credible founding teams. Pure biotech, drug discovery, and capital-intensive medical devices are not the firm’s stated focus. Check sizes typically span USD 1M to USD 5M at seed and Series A with selective follow-on, and the US geographic anchor with selective international healthcare deal flow remains the same. Best entry path is a warm introduction through a Wavemaker portfolio CEO, a healthcare ecosystem connector, or a US digital health banker, supplemented by direct outreach via LinkedIn or the website. Founders should be aware that engaging this firm twice through the duplicate slug will not change outcomes; pick one identifier and run a single, well-prepared process. Bring real clinical evidence, payer or provider commercial proof points, and a clear regulatory strategy to the first meeting, just as you would for the primary listing. Healthcare-fluent founders with credible traction will find a serious partner; generalist software pitches without sector depth will not.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Wavemaker Three-Sixty Health

Tools made by companies in Wavemaker Three-Sixty Health's portfolio that we cover in the directory.

SKOUT Software
Iterative Health
Gastroenterology AI

Portfolio companies in our directory

Other portfolio companies

Companies in Wavemaker Three-Sixty Health's portfolio not currently in our directory.

Team

John Nackel
Founder and General Partner
Jay Goss
General Partner
Maxim Owen
Partner
Tom Zenty
Executive-in-Residence
Monica Jain, MD
Venture Partner
Matt Michelson, PhD
Venture Partner and Head of AI
Kwame Ulmer
Venture Partner
LinkedIn

Pitch / review this investor

Have you raised from Wavemaker Three-Sixty Health? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.